Drawing for DO-MED

USPTO serial 87887625

DO-MED

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
SPARROW, MARY
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with DO-MED?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Rachel Rudensky

Rachel Rudensky Akerman LLP777 S. Flagler DriveSuite 1100, West TowerWest Palm Beach, FL 33401

Goods and services

ClassDescriptionStatusFirst use
009Computer software for healthcare professionals, particularly a computer software program for selecting optimal medications for patients; Computer software for transfer of medical records, namely, software that enables healthcare providers, medical institutes, hospitals, clinics, medical professionals, and insurance providers to receive patients' electronic medical records; Computer software that enables healthcare providers, medical institutes, hospitals, clinics and doctors, to calculate and recommend suitability of medications; Computer software for use by medical professionals in outpatient clinics, hospital environments, ambulatory, and home healthcare environments, particularly for providing a decision support system for medical decision-making activities remotely or through videoconferencing or designated input interface or mobile applications; Computer software for remotely monitoring patients' compliance with medical advice and medication regiments; Computer software for assisting in diagnosing a patient's clinical condition, namely, for assisting in analyzing symptoms and for providing a decision support systemACTIVE—
044Medical services; pharmacy advice services, namely, providing pharmaceutical consultation; medical consultancy services; medical examination services, namely, providing physical examinations to monitor the results of patient compliance with medical advice and medication regiments; medical diagnostic services; medical information services; medical clinic services; healthcare clinic services, namely, providing healthcare services; individual medical counseling services provided to patients; medical testing and analysis services for diagnosis or treatment purposes; medical services in the field of diabetes; medical analysis services for the diagnosis and treatment of persons; medical analysis services for treatment purposes; medical care and analysis services for treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 10, 2022MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 10, 2022ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 10, 2021DOCKASSIGNED TO EXAMINER—
May 19, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 18, 2021EX5GSOU EXTENSION 5 GRANTED—
May 18, 2021AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
May 10, 2021EXT5SOU EXTENSION 5 FILED—
May 10, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Sep 10, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Sep 8, 2020EX4GSOU EXTENSION 4 GRANTED—
Sep 8, 2020EXT4SOU EXTENSION 4 FILED—
Sep 8, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 2, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Apr 30, 2020EX3GSOU EXTENSION 3 GRANTED—
Apr 30, 2020EXT3SOU EXTENSION 3 FILED—
Apr 30, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 29, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 27, 2019EX2GSOU EXTENSION 2 GRANTED—
Nov 27, 2019EXT2SOU EXTENSION 2 FILED—
Nov 27, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 27, 2019ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 27, 2019REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
May 16, 2019EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 14, 2019EX1GSOU EXTENSION 1 GRANTED—
May 14, 2019EXT1SOU EXTENSION 1 FILED—
May 14, 2019EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 4, 2018NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 9, 2018NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 9, 2018PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 19, 2018NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 4, 2018ALIEASSIGNED TO LIE—
Aug 20, 2018CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 20, 2018XAECEXAMINER'S AMENDMENT ENTERED—
Aug 20, 2018GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Aug 20, 2018GNEAEXAMINERS AMENDMENT E-MAILED—
Aug 20, 2018CNEAEXAMINERS AMENDMENT -WRITTEN—
Aug 12, 2018DOCKASSIGNED TO EXAMINER—
May 1, 2018NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Apr 25, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance